Tommy Law - 16 Feb 2023 Form 3 Insider Report for NovaBay Pharmaceuticals, Inc. (NBY)

Role
Interim CFO
Signature
/s/ Tommy Law
Issuer symbol
NBY
Transactions as of
16 Feb 2023
Net transactions value
$0
Form type
3
Filing time
24 Feb 2023, 15:45:45 UTC
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding NBY Common Stock 0 16 Feb 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding NBY Stock Option (right to buy) 16 Feb 2023 Common Stock 143 $31.15 Direct F1
holding NBY Stock Option (right to buy) 16 Feb 2023 Common Stock 715 $34.65 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option grant will vest over four years, with 25% vesting on the first anniversary of the grant date and 6.25% vesting very three months thereafter.